Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1990 | 03-1990 | 12-1989 | 09-1989 | 06-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,767 | 1,885 | 1,940 | 2,327 | 3,007 |
| Marketable Securities | 0 | 563 | 1,182 | 686 | 962 |
| Receivables | 190 | 134 | 155 | 107 | 162 |
| Other current assets | 338 | 381 | 295 | 983 | 209 |
| TOTAL | $2,295 | $2,963 | $3,572 | $4,103 | $4,339 |
| Non-Current Assets | |||||
| Investments And Advances | 1,469 | 1,794 | 1,758 | 1,752 | 395 |
| Other Non-Current Assets | 558 | 557 | 553 | 581 | 1,255 |
| TOTAL | $2,027 | $2,351 | $2,310 | $2,332 | $1,650 |
| Total Assets | $4,683 | $5,683 | $6,242 | $6,736 | $6,301 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 98 | 198 | 151 | 87 | 83 |
| Accrued Expenses | 419 | 373 | 216 | 392 | 183 |
| TOTAL | $699 | $754 | $550 | $490 | $448 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,350 | 1,408 | 1,444 | 1,500 | 1,440 |
| TOTAL | $1,350 | $2,899 | $2,935 | $2,991 | $2,931 |
| Total Liabilities | $1,611 | $3,109 | $2,857 | $2,749 | $2,660 |
| Shareholders' Equity | |||||
| Common Shares | 50 | 50 | 50 | 50 | 48 |
| Retained earnings | -15,234 | -14,347 | -13,619 | -13,082 | -12,631 |
| Other shareholders' equity | 373 | 374 | 374 | 373 | 268 |
| TOTAL | $2,633 | $2,030 | $2,758 | $3,255 | $2,922 |
| Total Liabilities And Equity | $4,245 | $5,139 | $5,615 | $6,004 | $5,582 |